A proposal for cellularity assessment for EGFR mutational analysis with a correlation with DNA yield and evaluation of the number of sections obtained from cell blocks for immunohistochemistry in non-small cell lung carcinoma

被引:14
|
作者
Santos, Gilda da Cunha [1 ,2 ]
Wyeth, Tyler [2 ]
Reid, Allie [2 ]
Saieg, Mauro Ajaj [3 ]
Pitcher, Bethany [4 ,5 ]
Pintilie, Melania [4 ,5 ]
Kamel-Reid, Suzanne [1 ,2 ]
Tsao, Ming Sound [1 ,2 ]
机构
[1] Univ Hlth Network, Lab Med Program, Toronto, ON, Canada
[2] Univ Toronto, Dept Lab Med & Pathobiol, 200 Elizabeth St,11th Floor,Eaton Wing, Toronto, ON M5G 2C4, Canada
[3] Santa Casa Med Sch, Dept Pathol, Sao Paulo, Brazil
[4] Univ Hlth Network, Dept Biostat, Toronto, ON, Canada
[5] Princess Margaret Hosp, Toronto, ON M4X 1K9, Canada
关键词
GROWTH-FACTOR RECEPTOR; CYTOLOGICAL SPECIMENS; CANCER PATIENTS; KRAS MUTATIONS; GENE ANALYSIS; EXPERIENCE; SAMPLES; SMEARS;
D O I
10.1136/jclinpath-2015-203437
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
Aims Different approaches have been described for reporting specimen adequacy for epidermal growth factor receptor (EGFR) mutation analysis. We aimed: (1) to conduct cellularity assessment and to investigate its association with DNA yield, (2) to compare the H&E slides taken before and after the thick sections (curls) obtained for EGFR testing and (3) to evaluate the number of ancillary studies performed. Methods Cell block (CB) slides of 110 non-small cell lung carcinoma cases submitted to EGFR analysis from 2010 to 2012 were reviewed for total cellularity (ranges 1-100, 100-250, 250-500, 500-750, 750-1000 and > 1000 cells), tumour cellularity (ranges 1-50, 50-100, 100-300 and > 300 cells) and the percentage of tumour cells. Precurl and postcurl H&E slides were compared using the three criteria. The number of immunohistochemistry (IHC) markers and special stains and DNA yield were recorded. Results DNA yield was significantly associated with the total cellularity, number and percentage of tumour cells. For 46 cases with precurl and postcurl slides, only three (6.5%) were classified as being different and in two of them the postcurl slide had greater cellularity than the precurl. IHC was performed in 83 cases, with a minimum of 1 and a maximum of 11 markers (median of 3) per case. Conclusions An association between the total cellularity and the tumour cellularity with the DNA yield was demonstrated using the ranges described. Evaluation of a postcurl slide is an unnecessary practice. The majority of the CB had sufficient material for ancillary studies (up to 11 markers) and mutation testing.
引用
收藏
页码:607 / 611
页数:5
相关论文
共 50 条
  • [41] Evaluation of EGFR mutation testing in plasma from non-small cell lung cancer (NSCLC) patients
    Gonzalez De Aledo-Castillo, J. M.
    Victoria, I.
    Arcocha, A.
    Reguart, N.
    Molina Porto, R.
    Puig-Butille, J. A.
    CLINICA CHIMICA ACTA, 2019, 493 : S570 - S570
  • [42] Comparison of Four Leading Technologies for Detecting EGFR Mutations in Circulating Tumor DNA from Patients with Non-Small Cell Lung Carcinoma
    Kang, Xiaozheng
    Xu, Ting
    Xu, Guobin
    Chen, Ke-Neng
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (01) : S239 - S240
  • [43] ASSESSMENT OF MET AMPLIFICATION IN NON-SMALL CELL LUNG CARCINOMAS BY SISH: CORRELATION WITH EGFR AND KRAS MUTATIONS IN EARLY STAGES
    Conde, Esther
    Angulo, Barbara
    Suarez-Gauthier, Ana
    Garcia-Lujan, Ricardo
    Lopez-Encuentra, Angel
    Paz Ares, Luis
    Lopez-Rios, Fernando
    JOURNAL OF THORACIC ONCOLOGY, 2011, 6 (06) : S1080 - S1080
  • [44] EGFR expression and gene amplification in non-small cell lung carcinomas: Correlation between gene copy number and protein expression
    Kim, Ji Eun
    Lee, Hyun Ju
    Choe, Gheeyoung
    Jheon, Sanghoon
    Sung, Sook Whan
    Lee, Choon-Taek
    Chung, Jin-Haeng
    VIRCHOWS ARCHIV, 2008, 452 : S56 - S56
  • [45] Analysis of C-MET Amplification Non-Small Cell Lung Cancer Cell Blocks from Pleural Effusion
    Xu, C.
    Wang, W.
    Zhuang, W.
    Chen, G.
    Tian, Y.
    Xu, J.
    Fang, M.
    Lv, T.
    Song, Y.
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (11) : S1944 - S1945
  • [46] Analysis of ROS1 rearrangement non-small cell lung cancer cell blocks from pleural effusion
    Wang, W-X.
    Xu, C.
    Zhuang, W.
    Tian, Y.
    Xu, J.
    Fang, M.
    Chen, Y.
    Chen, G.
    Lv, T.
    Song, Y.
    JOURNAL OF THORACIC ONCOLOGY, 2018, 13 (04) : S17 - S17
  • [47] Assessment of MAGE-A Expression in Resected Non-Small Cell Lung Cancer in Relation to Clinicopathologic Features and Mutational Status of EGFR and KRAS
    Ayyoub, Maha
    Memeo, Lorenzo
    Alvarez-Fernandez, Emilio
    Colarossi, Cristina
    Costanzo, Rosario
    Aiello, Eleonora
    Martinetti, Daniela
    Valmori, Danila
    CANCER IMMUNOLOGY RESEARCH, 2014, 2 (10) : 943 - 948
  • [48] Screening for KRAS and EGFR mutations in circulating cell free tumour DNA from patients with non small cell lung carcinoma
    Gokhale, Carolyn
    Sherwood, J.
    Wallace, A.
    Elles, R.
    Ellison, G.
    JOURNAL OF MEDICAL GENETICS, 2010, 47 : S83 - S83
  • [49] Correlation between MET Gene Copy Number by Silver In Situ Hybridization and Protein Expression by Immunohistochemistry in Non-small Cell Lung Cancer
    Dziadziuszko, Rafal
    Wynes, Murry W.
    Singh, Shalini
    Asuncion, Bernadette Reyna
    Ranger-Moore, James
    Konopa, Krzysztof
    Rzyman, Witold
    Szostakiewicz, Barbara
    Jassem, Jacek
    Hirsch, Fred R.
    JOURNAL OF THORACIC ONCOLOGY, 2012, 7 (02) : 340 - 347
  • [50] Correlation Studies of EGFR Gene Amplification and Biomarker Protein Expression Levels in Untreated Non-Small Cell Lung Carcinoma (NSCLC)
    McKeegan, T.
    Jones, S.
    Jewell, S.
    Gewirtz, A.
    Zhao, W.
    JOURNAL OF MOLECULAR DIAGNOSTICS, 2008, 10 (06): : 605 - 605